Atransferrinemia
What is Atransferrinemia?
Atransferrinemia is an extremely rare genetic disorder where your body cannot make enough transferrin. Transferrin is a protein that carries iron through your bloodstream to where your body needs it. Without enough transferrin, iron gets stuck in your tissues instead of going where it belongs.
This condition creates a paradox in your body. You end up with severe anemia, which means your blood lacks healthy red blood cells, even though iron is building up in your organs. The iron overload can damage your liver, heart, and other organs over time. Most people inherit this condition from both parents, making it a recessive genetic disorder.
Only a few dozen cases have been reported worldwide since the condition was first discovered. Early diagnosis and treatment can help manage symptoms and prevent organ damage. Blood testing can reveal the characteristic pattern of low transferrin levels and abnormal iron distribution that defines this condition.
Symptoms
- Severe anemia starting in infancy or early childhood
- Pale skin, lips, and nail beds
- Extreme fatigue and weakness
- Shortness of breath during activity
- Delayed growth and development in children
- Frequent infections due to weakened immunity
- Enlarged liver or spleen
- Heart problems from iron buildup
- Dark urine from excess iron
Symptoms typically appear within the first few months of life. Because this condition is genetic, it affects people from birth even if signs take time to become obvious.
Concerned about Atransferrinemia? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Atransferrinemia is caused by mutations in the TF gene, which provides instructions for making transferrin protein. You must inherit a defective gene from both parents to develop this condition. When both gene copies are faulty, your body produces little to no functional transferrin. Parents who carry one mutated gene typically have no symptoms but can pass the condition to their children.
Risk factors include having parents who are blood relatives, which increases the chance of inheriting two copies of the same rare mutated gene. Certain populations with smaller gene pools may have slightly higher carrier rates. Unlike iron deficiency from diet, this condition cannot be prevented through lifestyle changes because it results from genetic programming present at conception.
How it's diagnosed
Doctors diagnose atransferrinemia through specialized blood tests that measure iron and transferrin levels. A Total Iron Binding Capacity test shows markedly decreased or absent transferrin in the blood. Transferrin Saturation measurements reveal abnormal calculations that point to this rare condition. These tests show the paradox of low blood iron alongside evidence of iron overload in tissues.
Rite Aid offers blood testing that includes TIBC and transferrin saturation measurements through our nationwide network of Quest Diagnostics locations. Genetic testing can confirm the diagnosis by identifying mutations in the TF gene. Doctors may also order liver function tests and imaging studies to check for organ damage from iron deposits.
Treatment options
- Regular transferrin infusions to replace the missing protein
- Iron chelation therapy to remove excess iron from tissues
- Blood transfusions in severe cases of anemia
- Careful monitoring of organ function, especially liver and heart
- Avoiding iron supplements, which worsen iron overload
- Treating infections promptly due to weakened immunity
- Working with a hematologist experienced in rare blood disorders
- Regular blood testing to track treatment response
Concerned about Atransferrinemia? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Atransferrinemia causes anemia despite iron overload in your tissues, not iron deficiency. Your body has too much iron but cannot transport it properly because transferrin protein is missing. Regular iron deficiency anemia involves too little iron overall and improves with iron supplements. Taking iron supplements with atransferrinemia actually makes the condition worse by adding more iron that cannot be properly distributed.
Atransferrinemia is extremely rare, with only a few dozen documented cases worldwide. It affects fewer than 1 in 1,000,000 people. The condition is so uncommon that many doctors never encounter it during their careers. Genetic testing and specialized blood work are needed to identify it.
There is currently no cure for atransferrinemia because it results from permanent genetic mutations. Treatment focuses on managing symptoms and preventing complications through regular transferrin infusions. Iron chelation therapy helps remove excess iron from organs. With consistent treatment, many people can maintain better health and reduce organ damage risk.
Blood tests show markedly decreased or absent Total Iron Binding Capacity, which measures transferrin levels in your blood. Transferrin saturation calculations appear severely abnormal. Serum iron may be low despite iron overload in your tissues. These test results together create a distinctive pattern that suggests this rare genetic condition.
Yes, atransferrinemia is an autosomal recessive genetic disorder. You must inherit one mutated TF gene from each parent to develop the condition. Parents who carry one mutated gene are typically healthy but can pass it to children. If both parents are carriers, each child has a 25 percent chance of having atransferrinemia.
Without enough transferrin to carry iron through your bloodstream, iron cannot reach your bone marrow to make red blood cells. Instead, iron accumulates in organs like your liver, heart, and pancreas. This creates toxic deposits that damage tissues over time. The body keeps absorbing iron from food, worsening the overload problem.
Treatment frequency varies based on symptom severity and individual needs. Transferrin infusions may be needed weekly or several times per month. Iron chelation therapy often continues long term to manage iron overload. Regular blood testing every few months helps doctors adjust treatment plans and monitor organ health.
Women with atransferrinemia face increased risks during pregnancy due to severe anemia and organ damage. Pregnancy increases iron demands, which can worsen symptoms. Close monitoring by maternal-fetal medicine specialists is essential. Genetic counseling helps couples understand the risk of passing the condition to children.
Untreated atransferrinemia can cause permanent organ damage from iron deposits in the liver, heart, and pancreas. Liver cirrhosis, heart failure, and diabetes may develop. Severe anemia weakens immunity and increases infection risk. Growth delays and developmental problems occur in children without treatment.
Yes, genetic testing for family members can identify carriers of the TF gene mutation. Parents and siblings have the highest risk of being carriers. Knowing carrier status helps with family planning decisions. Blood relatives considering having children together should discuss genetic testing and counseling.